Ganesha, the US fda has nothing to do with approving the Brazilian protocol. It's all up to Anvisa. Now, when the trial progresses and he hit interim, (120 or 40%), and the results are really exceptional, ( I am in this camp), the US fda can use it toward a US approval for EUA only, not approval. I believe this to be true but someone can correct me if I'm wrong -

GLTU and relax over the weekend as our stress for the weekend is subsiding some what and that goes for all here on the board and we all need a breather from this crazy trading pattern that has us mired in mud with what we saw on L-2 this week

HCIT